98%
921
2 minutes
20
Posaconazole is a broad-spectrum antifungal agent exhibiting rich polymorphism. Up to now, a total of fourteen different crystal forms have been reported, sometimes with an ambiguous nomenclature, but less is known about their properties and stability relationships. Investigating the solid-state of a drug compound is essential to identify the most stable form under working conditions and to prevent the risk of undesired solid-phase transformations under processing and storage. In this paper, we study posaconazole polymorphism by providing a description of its polymorphs, hydrates, and solvates. Powder X-ray diffraction (PXRD), dynamic vapor sorption (DVS), spectroscopic and thermal techniques were employed to characterize the different forms. In addition, the solid-phase transformations of posaconazole in aqueous suspensions were studied by means of Raman microscopy. Surprisingly, we found that Form S, the crystal form contained in the marketed oral suspension, is not the most stable form in water. Form S readily converts to a more stable hydrate, i.e. Form A, after storage in water for two weeks. In the commercial oral formulation the conversion between the two forms is prevented by the presence of polysorbate 80. Such insights into the stabilizing excipient effects beyond particle dispersion are critical to formulators.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ejps.2024.106722 | DOI Listing |
Org Lett
August 2025
Institute of Pharmaceutical Science and Technology, Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, People's Republic China.
A highly efficient and concise bromocyclization has been successfully achieved, in which chiral auxiliary-substituted 4-en-1-ol derivatives can be transformed to valuable THF scaffolds in an economic and green manner. Production was successfully scaled up under both batch and continuous flow processes. A distinctive feature of our synthetic approach is that water constitutes the primary byproduct.
View Article and Find Full Text PDFMol Biol Rep
June 2025
Department of Medicine, BGS Global Institute of Medical Sciences, No. 67, BGS Health and Education City, Uttarahalli Road, Kengeri, Bengaluru, 560060, Karnataka, India.
Background: A substantial rise in the less common Trichophyton tonsurans in India with notable multi-drug resistance has transformed into a reason for recalcitrant dermatophytosis and concern.
Methods And Results: In the current investigation, we isolated 'resistant' strains of T. tonsurans from clinical samples and studied the transcriptional modulation of the drug efflux transporter genes upon challenge with sub-lethal doses of various antifungal agents.
mBio
August 2024
Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, North Carolina, USA.
Unlabelled: Mucormycoses are emerging fungal infections caused by a variety of heterogeneous species within the Mucorales order. Among the species complex, is the most frequently isolated pathogen in mucormycosis patients and despite its clinical significance, there is an absence of established genome manipulation techniques to conduct molecular pathogenesis studies. In this study, we generated a spontaneous uracil auxotrophic strain and developed a genetic transformation procedure to analyze molecular mechanisms conferring antifungal drug resistance.
View Article and Find Full Text PDFZhonghua Jie He He Hu Xi Za Zhi
July 2024
The prevalence of pulmonary aspergillosis is increasing in patients with chronic obstructive pulmonary disease (COPD) and can manifest in different forms such as invasive pulmonary aspergillosis (IPA), chronic pulmonary aspergillosis (CPA) and allergic bronchopulmonary aspergillosis (ABPA). With the variations of individual conditions such as immune status, these forms of the disease may transform into each other or even overlap. Moreover, the atypical clinical manifestations and the limited use of invasive sampling techniques have posed a challenge to the diagnosis and treatment of invasive pulmonary aspergillosis in patients with COPD.
View Article and Find Full Text PDFEur J Pharm Sci
April 2024
Solvias AG, Solid-State Development Department, Römerpark 2, Kaiseraugst CH- 4303, Switzerland. Electronic address:
Posaconazole is a broad-spectrum antifungal agent exhibiting rich polymorphism. Up to now, a total of fourteen different crystal forms have been reported, sometimes with an ambiguous nomenclature, but less is known about their properties and stability relationships. Investigating the solid-state of a drug compound is essential to identify the most stable form under working conditions and to prevent the risk of undesired solid-phase transformations under processing and storage.
View Article and Find Full Text PDF